Gulf War Syndrome
- The Burlington Free Press, 06/15/2002:
Sanders to
address British Parliament
Gulf War Syndrome
- The report to Congress 11/07/97
[contents]:
Union Calendar
No. 228
Back To:
Primal Scream:
Beyond the Box
Links:
GulfWeb.org
GulfLink.mil
|
commentary
An Open Letter to The Burlington Free Press
The Burlington Free Press reported on June 15, 2002, that U.S.
Congressional Representative Bernie Sanders would be appearing before
the British Parliament to urge both the American and British
governments to acknowledge the existence of and take responsibility
for Gulf War Syndrome. The former mayor of Burlington, now Vermont’s
lone Congressman, has long been active on this particular issue. One
would expect that the Free Press would take a certain pride in their
former mayor, and would perhaps go a little further than they might
otherwise, in presenting the evidence that already exists regarding
Gulf War Syndrome. This is not the case.
Instead the article reads like any other touching on scientific issues
that suffer from political dispute: utterly unbiased, totally
non-committal in its presentation of both sides of the issue - as if
the vociferous sources of denial had any credibility what so ever.
The article cites the major players and their positions, rather than
the body of evidence. Players such as the Veterans Administration
and the British defense department, neither of which has recognized
the human suffering of service personnel exposed to what has finally
been acknowledged as a ’chemical cesspool.’
In referring to chemical munitions destroyed by U.S. military personnel,
the Free Press
cites the Congressman,
rather than the body of evidence that has been gathered since the Gulf
War. This seems to suggest that the Congressman is simply stating an
assertion, as if the matter were still in some doubt.
The Congressional Report of November 7, 1997 makes it quite clear that
U.S. forces not only destroyed chemical weapons at a bunker storage
site at
Khamisiyah,
[and page 80]
but at other chemical weapon storage sites as well, including
Ukhaydir and
Mymona,
and a production facility at
Muthanna.
[and page 72, 79]
Evidence presented to Congress supports the assertion that exposures
of U.S. troops to chemical warfare agents was more than simply a
consequence of this destruction, it was
predicted.
Clearly, the Congressman is not simply stating an opinion. It is
rather a fact, one which the Department of Defense ceased to deny on
June 21, 1996.
Far worse than this passive/aggressive method of referring to events
that are fully substantiated and by now common knowledge, is the
failure of the Burlington Free Press to list what is perhaps the
single most significant source of chemical exposure experienced by
Gulf War vets. Rarely in its coverage of Gulf War Syndrome has the
Free Press ever mentioned
"Experimental Drugs and Vaccines",
a subject that received attention by the Committee on Government
Reform and Oversight, and is given its own section in the report from
that committee, [
House Report 105-388 - Gulf War Veterans’ Illnesses:
VA, DOD Continue To Resist Strong Evidence Linking Toxic Causes To
Chronic Health Effects] beginning on page 33.
In fact, in every article I have read, the Free Press has consistently
ignored this committee’s report in its entirety, and almost never
mentions PB [pyridostigmine bromide] pills.
From page 33 of the report:
Experimental Drugs and Vaccines
In December 1990, a month before the war, the Food and Drug
Administration [FDA] agreed to issue a waiver to the DOD allowing the
military to issue experimental drugs and vaccines to U.S. personnel in
the Gulf without first obtaining informed consent. A factor possibly
contributing to the illnesses of Gulf veterans was the ingestion of
anti-nerve gas pills, pyridostigmine bromide tablets [PB tabs].
Troops were required to take the experimental drug to counter the
effects of potential exposure to chemical warfare agents.
PB expert Dr. Thomas Tiedt, a neuroscientist and former
pharmaceutical industry researcher, testified before the Human
Resources Subcommittee that "evidence shows that Gulf War Syndrome
was easily predicted. The symptoms largely match those of cholinergic
syndrome, which results from inhibition of the life-critical and
development-critical enzyme acetylcholinesterase [AchE].
Pyridostigmine bromide, Sarin, and organophosphate pesticides are
examples of AchE inhibitors . . . [which] cause stunning nerve and
muscle degeneration moments after a single dose, which worsens with
multiple doses"130
"My team's research at the University of Maryland during the
mid-1970's about physiological and microscopic AchE toxicity was
comprehensive," Dr. Tiedt stated. "Our work was followed by an
explosion of research by DOD during the 1980's, the most relevant of
which was produced by my co-authors and colleagues at Maryland and the
[Army's] chemical-warfare R&D center in Aberdeen [MD]. DOD [research]
established by the early 1980's that; 1) PB would be harmful in
healthy individuals; 2) PB was worthless, even counterproductive, as
a protectant against chemical warfare; and 3) PB was more toxic than
sub-lethal doses of chemical warfare agents. I understand PB was taken
by about 500,000 soldiers . . . [and] it has been reported that
50-60 percent of soldiers taking PB have acute side effects."131
Dr. Tiedt concluded: "More attention is needed on the long record
by the military to conduct involuntary, meritless, and hazardous
experiments on soldiers. The Nuremberg Code [signed following World
War II] states, 'No experiments should be conducted where there is an
a priori reason to believe that death or disabling injury will occur.'
The use of PB was an experiment. It was the first time we used PB for
such a purpose. There were no data supporting its use or the way it
was used. Sadly, no records remain or were kept."132
130 Statement of Thomas Tiedt, Human Resources Subcommittee hearing, No. 2,
p. 301.
131 Ibid., p. 303.
132 Ibid., p. 306.
The report makes it quite clear. The use of PB was experimental,
[page 33, 81].
As such its use required a waiver of informed consent by the DOD from
the FDA, which was approved on December 21, 1990 [page
110].
This was done inspite of research during the mid 1980’s demonstrating,
in the words of Dr. Tiedt, that PB is not only "worthless as a protectant
against chemical warfare, . . . [it is] more toxic than sub-lethal
doses of chemical warfare agents."
Dr. Tiedt’s concluding remarks bear repeating: "The use of PB was
an experiment. It was the first time we used PB for such a purpose.
There were no data supporting its use or the way it was used. Sadly,
no records remain or were Kept."
If the federal government permits the circumvention of the Nuremberg
Code, thus clearing the way for human experimentation without the
consent of the test subjects, experimentation that is not only life
threatening, but for which there exists no supporting data, then the
potential consequences to the public health are dire, as is amply
demonstrated by the thousands of veterans suffering from Gulf War
Syndrome.
That the Burlington Free Press should fail to report these facts in
its coverage of Gulf War Syndrome is not only inexplicable, it is
utterly unacceptable.
Sincerely,
D. Winter Burlington, Vermont
|
|
|
Page 12A
The Burlington Free Press
Saturday,
June 15, 2002
Sanders to address British Parliament
Vt. congressman will discuss treatment for Gulf War veterans
By Erin Kelly
Free Press Washington Writer
WASHINGTON - Rep. Bernie Sanders will address the British Parliament next week to call
on the British and American governments to work together to help veterans suffering from Gulf War
related illnesses and to research the causes.
"My message is we have a moral responsiblity to understand the cause of Gulf War Illness on behalf
of the 100,000-plus American soldiers and 5,000 British soldiers who suffer from it," Sanders,
I-Vt., said Friday. "We've got to make sure that all of these soldiers receive the compensation
to which they are entitled."
Sanders is a member of the House Subcommittee on National Security, Veterans Affairs and International
Relations and has been pushing for the U.S. government to fund research and treatment of Gulf War
Syndrome for more than a decade.
The Vermonter will speak before a joint session of the British House of Lords and House of Commons on
Wednesday. He also will meet with British lawmakers, researchers and military officials to talk about
increased cooperation between the two countries. Sanders and two other House members also will meet
with English soldiers who are suffering from symptoms.
Sanders said research will benefit not only veterans but civilians who have been exposed to toxic
chemicals and share many of the same symptoms. Those symptoms include headaches, chronic fatigue,
rashes, joint and muscle pain, memory loss, depression and reproductive problems.
Gulf War veterans were exposed to a highly toxic environment, including pesticides, diesel fuel,
depleted uranium, emissions from oil well fires, and chemical agents that were stored by the Iraqis.
U.S. soldiers detonated the weapons to destroy them,
Sanders said.
**
The Veterans Administration has never officially acknowledged that Gulf War Syndrome exists, but it
did recently acknowledge that Gulf War vets are nearly twice as likely as soldiers who did not fight
there to develop Lou Gehrig's Disease, a fatal disease of the nervous system.
"That was a major break-through and, in my view, it will be the first of many acknowledgements on
the part of the VA that Gulf War Illness is a real disease," Sanders said.
The British defense department has not recognized the existence of the disease, but a British pension
appeals tribunal recently ruled that the illness is real.
Sanders will be accompanied by Rep. Chris Shays, R-Conn., chairman of the veterans' affairs subcommittee;
Rep. Adam Putnam, R-Fla., and Texas billionaire H. Ross Perot, who has funded research into Gulf War
Syndrome. Researcher Dr. Robert Haley of the University of Texas also will be part of the U.S.
contingent.
**
Emphasis added for
electronic publication.
|
|